HDAC7 Antibody - #AF5475
製品説明
*The optimal dilutions should be determined by the end user.
*Tips:
WB: For western blot detection of denatured protein samples. IHC: For immunohistochemical detection of paraffin sections (IHC-p) or frozen sections (IHC-f) of tissue samples. IF/ICC: For immunofluorescence detection of cell samples. ELISA(peptide): For ELISA detection of antigenic peptide.
引用形式: Affinity Biosciences Cat# AF5475, RRID:AB_2837957.
折りたたみ/展開
DKFZP586J0917; FLJ99588; HD 7a; HD7; HD7a; HDAC 7; HDAC 7A; Hdac7; HDAC7_HUMAN; HDAC7A; Histone deacetylase 7; Histone deacetylase 7A; OTTHUMP00000202813; OTTHUMP00000202814;
免疫原
- Q8WUI4 HDAC7_HUMAN:
- Protein BLAST With
- NCBI/
- ExPASy/
- Uniprot
MDLRVGQRPPVEPPPEPTLLALQRPQRLHHHLFLAGLQQQRSVEPMRLSMDTPMPELQVGPQEQELRQLLHKDKSKRSAVASSVVKQKLAEVILKKQQAALERTVHPNSPGIPYRTLEPLETEGATRSMLSSFLPPVPSLPSDPPEHFPLRKTVSEPNLKLRYKPKKSLERRKNPLLRKESAPPSLRRRPAETLGDSSPSSSSTPASGCSSPNDSEHGPNPILGSEALLGQRLRLQETSVAPFALPTVSLLPAITLGLPAPARADSDRRTHPTLGPRGPILGSPHTPLFLPHGLEPEAGGTLPSRLQPILLLDPSGSHAPLLTVPGLGPLPFHFAQSLMTTERLSGSGLHWPLSRTRSEPLPPSATAPPPPGPMQPRLEQLKTHVQVIKRSAKPSEKPRLRQIPSAEDLETDGGGPGQVVDDGLEHRELGHGQPEARGPAPLQQHPQVLLWEQQRLAGRLPRGSTGDTVLLPLAQGGHRPLSRAQSSPAAPASLSAPEPASQARVLSSSETPARTLPFTTGLIYDSVMLKHQCSCGDNSRHPEHAGRIQSIWSRLQERGLRSQCECLRGRKASLEELQSVHSERHVLLYGTNPLSRLKLDNGKLAGLLAQRMFVMLPCGGVGVDTDTIWNELHSSNAARWAAGSVTDLAFKVASRELKNGFAVVRPPGHHADHSTAMGFCFFNSVAIACRQLQQQSKASKILIVDWDVHHGNGTQQTFYQDPSVLYISLHRHDDGNFFPGSGAVDEVGAGSGEGFNVNVAWAGGLDPPMGDPEYLAAFRIVVMPIAREFSPDLVLVSAGFDAAEGHPAPLGGYHVSAKCFGYMTQQLMNLAGGAVVLALEGGHDLTAICDASEACVAALLGNRVDPLSEEGWKQKPNLNAIRSLEAVIRVHSKYWGCMQRLASCPDSWVPRVPGADKEEVEAVTALASLSVGILAEDRPSEQLVEEEEPMNL
種類予測
Score>80(red) has high confidence and is suggested to be used for WB detection. *The prediction model is mainly based on the alignment of immunogen sequences, the results are for reference only, not as the basis of quality assurance.
High(score>80) Medium(80>score>50) Low(score<50) No confidence
PTMs - Q8WUI4 基板として
Site | PTM Type | Enzyme | Source |
---|---|---|---|
S42 | Phosphorylation | Uniprot | |
S49 | Phosphorylation | Uniprot | |
K86 | Ubiquitination | Uniprot | |
K96 | Ubiquitination | Uniprot | |
T104 | Phosphorylation | Uniprot | |
S109 | Phosphorylation | Uniprot | |
Y114 | Phosphorylation | Uniprot | |
T153 | Phosphorylation | Uniprot | |
S155 | Phosphorylation | Q7KZI7 (MARK2) , Q15139 (PRKD1) , P27448 (MARK3) , Q13131 (PRKAA1) , O43318 (MAP3K7) , P98161 (PKD1) | Uniprot |
K160 | Sumoylation | Uniprot | |
K160 | Ubiquitination | Uniprot | |
S181 | Phosphorylation | Uniprot | |
S185 | Phosphorylation | Uniprot | |
T247 | Phosphorylation | Uniprot | |
T255 | Phosphorylation | Uniprot | |
R277 | Methylation | Uniprot | |
S283 | Phosphorylation | Uniprot | |
T286 | Phosphorylation | Uniprot | |
T301 | Phosphorylation | Uniprot | |
S354 | Phosphorylation | Uniprot | |
T356 | Phosphorylation | Uniprot | |
S358 | Phosphorylation | Q13131 (PRKAA1) , Q15139 (PRKD1) | Uniprot |
S364 | Phosphorylation | Uniprot | |
T366 | Phosphorylation | Uniprot | |
K382 | Sumoylation | Uniprot | |
S391 | Phosphorylation | Uniprot | |
S405 | Phosphorylation | Uniprot | |
S464 | Phosphorylation | Uniprot | |
S482 | Phosphorylation | Uniprot | |
S486 | Phosphorylation | Q15139 (PRKD1) | Uniprot |
S487 | Phosphorylation | Uniprot | |
S493 | Phosphorylation | Uniprot | |
S507 | Phosphorylation | Uniprot | |
S508 | Phosphorylation | Uniprot | |
T511 | Phosphorylation | Uniprot | |
T515 | Phosphorylation | Uniprot | |
Y524 | Phosphorylation | Uniprot | |
S526 | Phosphorylation | Uniprot | |
K530 | Methylation | Uniprot | |
K530 | Ubiquitination | Uniprot | |
S534 | Phosphorylation | Uniprot | |
K571 | Ubiquitination | Uniprot | |
S573 | Phosphorylation | Uniprot | |
S595 | Phosphorylation | Uniprot | |
K603 | Acetylation | Uniprot | |
K603 | Ubiquitination | Uniprot | |
K893 | Ubiquitination | Uniprot | |
S903 | Phosphorylation | Uniprot | |
S907 | Phosphorylation | Uniprot |
研究背景
Responsible for the deacetylation of lysine residues on the N-terminal part of the core histones (H2A, H2B, H3 and H4). Histone deacetylation gives a tag for epigenetic repression and plays an important role in transcriptional regulation, cell cycle progression and developmental events. Histone deacetylases act via the formation of large multiprotein complexes. Involved in muscle maturation by repressing transcription of myocyte enhancer factors such as MEF2A, MEF2B and MEF2C. During muscle differentiation, it shuttles into the cytoplasm, allowing the expression of myocyte enhancer factors (By similarity). May be involved in Epstein-Barr virus (EBV) latency, possibly by repressing the viral BZLF1 gene. Positively regulates the transcriptional repressor activity of FOXP3. Serves as a corepressor of RARA, causing its deacetylation and inhibition of RARE DNA element binding. In association with RARA, plays a role in the repression of microRNA-10a and thereby in the inflammatory response.
May be phosphorylated by CaMK1. Phosphorylated by the PKC kinases PKN1 and PKN2, impairing nuclear import. Phosphorylation at Ser-155 by MARK2, MARK3 and PRKD1 promotes interaction with 14-3-3 proteins and export from the nucleus. Phosphorylation at Ser-155 is a prerequisite for phosphorylation at Ser-181.
Nucleus. Cytoplasm.
Note: In the nucleus, it associates with distinct subnuclear dot-like structures. Shuttles between the nucleus and the cytoplasm. Treatment with EDN1 results in shuttling from the nucleus to the perinuclear region. The export to cytoplasm depends on the interaction with the 14-3-3 protein YWHAE and is due to its phosphorylation.
Interacts with HDAC1, HDAC2, HDAC3, HDAC4, HDAC5, NCOR1, NCOR2, SIN3A, SIN3B, RBBP4, RBBP7, MTA1L1, SAP30 and MBD3. Interacts with the 14-3-3 protein YWHAE, MEF2A, MEF2B and MEF2C (By similarity). Interacts with KAT5 and EDNRA. Interacts with KDM5B. Interacts with ZMYND15 (By similarity). Interacts with PML (isoform PML-4). Interacts with FOXP3. Interacts with RARA.
The nuclear export sequence mediates the shuttling between the nucleus and the cytoplasm.
Belongs to the histone deacetylase family. HD type 2 subfamily.
研究領域
· Human Diseases > Substance dependence > Alcoholism.
· Human Diseases > Infectious diseases: Viral > Human papillomavirus infection.
· Human Diseases > Cancers: Overview > Viral carcinogenesis.
Restrictive clause
Affinity Biosciences tests all products strictly. Citations are provided as a resource for additional applications that have not been validated by Affinity Biosciences. Please choose the appropriate format for each application and consult Materials and Methods sections for additional details about the use of any product in these publications.
For Research Use Only.
Not for use in diagnostic or therapeutic procedures. Not for resale. Not for distribution without written consent. Affinity Biosciences will not be held responsible for patent infringement or other violations that may occur with the use of our products. Affinity Biosciences, Affinity Biosciences Logo and all other trademarks are the property of Affinity Biosciences LTD.